Table 1.
Virus strain | Host system | Techniques | No. of host factors identified | Year | Reference |
---|---|---|---|---|---|
A2 | A549 | Microarray | 306 | 2001 | Zhang et al. [8] |
Long | HeLa | Microarray | 380 | 2002 | Tian et al. [9] |
A2 | BALB/c mice | Microarray | 411 | 2007 | Janssen et al. [10] |
Long | A549 | Microarray | 377 | 2007 | Martinez et al. [11] |
A2 | Various cell lines | Microarray | 184 | 2007 | Mayer et al. [12] |
Circulating strain | Pediatric patients (whole blood) | Microarray | 395 | 2013 | Meijas et al. [13] |
Circulating strain | Pediatric patients (PBMC) | Microarray | 293 | 2015 | Brand et al. [14] |
A2 | A549 | 2DE; MALDI-TOF-MS | 19 | 2004 | Brasier et al. [15] |
A2 | A549; Vero | 2D-DIGE; LC–MS/MS | 22 | 2012 | Hastie et al. [16] |
A2 | A549 | 2D-DIGE; MALDI-TOF-MS | 34 | 2010 | Jamaluddin et al. [17] |
A2 | A549 | 2D-DIGE; LC–MS/MS | 14 | 2010 | van Diepen et al. [18] |
A2 | A549 (SILAC) | SDS-PAGE; LC–MS/MS | 431 | 2010 | Munday et al. [19] |
Subgroup B | A549 (SILAC) | SDS-PAGE; LC–MS/MS | 112 | 2010 | Munday et al. [20] |
A2 | HEp2 | In-solution IEF; LC–MS/MS | 69 | 2011 | Ternette et al. [21] |
A2 | A549 | In-solution IEF; LC–MS/MS | 146 | 2014 | Dave et al. [22] |
Recombinant vaccine (F,G) | BALB/c mice | SDS-PAGE; LC–MS/MS | 48 | 2015 | van Diepen et al. [23] |
PBMC: peripheral blood mononuclear cell; SILAC: stable isotope labeling with amino acids in cell culture; 2DE: two-dimensional gel electrophoresis; 2D-DIGE: two-dimensional differential gel electrophoresis; SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis; IEF: isoelectric focusing; MALDI-TOF-MS: matrix-assisted laser desorption ionization-time of flight-mass spectrometry; LC–MS/MS: liquid chromatography–tandem mass spectrometry